XINT — Xintela AB Share News
0.000.00%
Last trade - 00:00- SEK200.68m
- SEK190.89m
- SEK2.28m
Brief: Xintela Gets About SEK 3 Mln From Rights Issue
Brief: Xintela Q1 Pretax Loss Narrows To SEK 7.5 Mln
Brief: Xintela Takes Up Loan Of SEK 18.9 Million
Brief: Xintela Receives 1 Million Sek From Vinnova
Brief: Xintela Postpones AGM
Brief: Xintela Granted SEK 2 Mln From Vinnova
Brief: Xintela Q4 Pretax Loss Widens To SEK 10.0 Mln
Brief: Xintela Publishes Positive Preclinical Results From Equine Study
Brief: Xintela Updates On Existing And New Loan Facilities
Brief: Xintela Announces Positive Preclinical Results In Glioblastoma Project
Brief: Xintela Q3 Loss Before Tax Widens To SEK 8.0 Mln
Brief: Xintela Gets Loan Of Around SEK 8 Million
Brief: Xintela Q2 Pre-Tax Loss Widens To SEK 10.7 Mln
Brief: Xintela Q1 Pretax Loss Widens To SEK 9.5 Million
Brief: Xintela Q4 Pretax Loss Widens To SEK 8.7 Million
Brief: Xintela Broadens And Extends Patent Protection For Chondrocyte Products
Brief: Xintela Q3 Pretax Loss At SEK 4.4 Million
Develop Brain Cancer Therapy
Brief: Xintela Proposes Directed Issue Of Up To 8.3 Mln Shares To Bauerfeind